BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5437035)

  • 1. Studies on the site of action of persantin, segontin and trimanyl. Their effect on the bioelectric activity of rabbit's brain.
    Janicki K; Trabka J; Gatarski J
    Pol Med J; 1970; 9(1):1816. PubMed ID: 5437035
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K; Wcislo W
    Pol Tyg Lek; 1967 May; 22(21):779-81. PubMed ID: 6040998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Additional studies on the effect of Segontin on the central nervous system].
    Vieth J; Preiss D
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):283-302. PubMed ID: 5968512
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficiency of human cardiac action by coronary dilators].
    Schirmer R; Hamacher J
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):440. PubMed ID: 4253863
    [No Abstract]   [Full Text] [Related]  

  • 5. [The coronary dilatator effect of various reference drugs].
    Duchene-Marullaz P; Cosnier D; Grimald J
    Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of Segontin, Persantin and nitroglycerin on the coronary artery. Experimental studies with cinecoronarography.
    DAHL M; KASANEN A; PELTONEN T
    Ann Med Exp Biol Fenn; 1962; 40():423-6. PubMed ID: 14024623
    [No Abstract]   [Full Text] [Related]  

  • 7. [New data on the drug therapy of angina pectoris].
    Urbaszek W
    Z Gesamte Inn Med; 1966 Nov; 21(21):641-9. PubMed ID: 5994727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent data on coronary dilators].
    Duchêne-Marullaz P; Lavarenne J
    Actual Pharmacol (Paris); 1968; 21():65-116. PubMed ID: 4890107
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the mode of action of prenylamine (Segontin) and other coronary dilating drugs in man.
    Schmid E; Bachmann K; Krautheim J; Heynen HP
    Indian Heart J; 1968 Apr; 20(2):133-40. PubMed ID: 5738423
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of coronary-active substances on the uptake of adenosine in the isolated, beating heart].
    Volkmer I; Pfleger K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):155-6. PubMed ID: 4979632
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the effectiveness of orally administered coronary dilator agents].
    Rudolph W; Brand E; Dietze G; Wicklmayr M
    Verh Dtsch Ges Inn Med; 1968; 74():1031-5. PubMed ID: 5714231
    [No Abstract]   [Full Text] [Related]  

  • 12. [Screening of substances with coronary vasodilator action].
    Lenke D
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of coronary insufficiency].
    NANBA H
    Sogo Rinsho; 1963 Jul; 12():1378-85. PubMed ID: 13937539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the mechanism of action of prenylamine].
    Lindner E
    Arzneimittelforschung; 1969 Jan; 19(1):15-9. PubMed ID: 5819360
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with the clinical use of Segontin in coronary disease].
    OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K
    Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Jul; 56(7):716-44. PubMed ID: 5592004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of coronary circulatory disorders in internal practice with segontin].
    HAMANN E
    Landarzt; 1961 Nov; 37():1277-9. PubMed ID: 13904049
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with segontin].
    RATSCHOW M; SCHOOP W
    Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.